Article Publish Status: FREE
Abstract Title:

Polysaccharide Inhibited Hypoxia-Inducible Factor 1 in COPD Patients.

Abstract Source:

Int J Chron Obstruct Pulmon Dis. 2020 ;15:1997-2004. Epub 2020 Aug 24. PMID: 32921997

Abstract Author(s):

Li-Jun Chen, Wang Xu, Ya-Ping Li, Li-Ting Ma, Hui-Fang Zhang, Xiao-Bo Huang, Geng-Geng Yu, Xiu-Qin Ma, Chao Chen, Yan-Hong Liu, Jie Wu, Li-Jun Wang, Yuan Xu

Article Affiliation:

Li-Jun Chen


Background: Chronic obstructive pulmonary disease (COPD) is a chronic airway inflammatory disease characterized by irreversible airflow obstruction. Pathogenic mechanisms underlying COPD remain largely unknown.

Objective: The current study was designed to explore serum concentration of hypoxia-inducible factor 1α (HIF-1α) in stable COPD patients and the potential effect ofpolysaccharides (LBP) on HIF-1α protein expression.

Methods: Serum HIF-1α was quantified by ELISA in 102 stable COPD patients before and after 2-week orally taken LBP (100 mL/time, twice daily, 5-15 mg/mL). Correlation of serum LBP and lung function (FEV1%) or blood gas (POand PCO) was also analyzed. As a control, 105 healthy subjects were also enrolled into this study.

Results: Serum concentration of HIF-1α was significantly higher in the stable COPD patients (37.34 ± 7.20 pg/mL) than that in the healthy subjects (29.55 ± 9.66 pg/mL,<0.001). Oral administration of LBP (5 mg/mL, 100 mL, twice daily for 2 weeks) not only relieved COPD symptoms but also significantly reduced serum HIF-1α concentration (36.94 ± 9.23 vs 30.49 ± 6.42 pg/mL,<0.05). In addition, level of serum HIF-1α concentration was significantly correlated with PCO(r = 0.283,<0.001), but negatively and significantly correlated with PO(r = -0.490,=0.005) or FEV1%(r = -0.420,=0.018).

Conclusion: These findings suggested that activation of HIF-1 signaling pathway may be involved in the pathophysiology of COPD and that stabilization of serum HIF-1α concentration by LBP might benefit the stable COPD patients.

Study Type : Human Study

Print Options

Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2022 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.